Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Clinical Autonomic Research
Erschienen in: Clinical Autonomic Research 3/2015

01.06.2015 | Review Article

Cardiovascular complications in patients with autonomic failure

verfasst von: Valeria Milazzo, Cristina Di Stefano, Alberto Milan, Agnese Ravera, Gabriele Sobrero, Luca Sabia, Franco Veglio, Simona Maule

Erschienen in: Clinical Autonomic Research | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Patients with autonomic failure are characterized by orthostatic hypotension, supine hypertension, high blood pressure variability, blunted heart rate variability, and often have a “non-dipping” or “reverse dipping” pattern on 24-h ambulatory blood pressure monitoring. These alterations may lead to cardiovascular and cerebrovascular changes, similar to the target organ damage found in hypertension. Often patients with autonomic failure are on treatment with anti-hypotensive drugs, which may worsen supine hypertension. The aim of this review is to summarize the evidence for cardiac, vascular, renal, and cerebrovascular damage in patients with autonomic failure.
Literatur
1.
Freeman R (2008) Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med 358(6):615–624PubMedCrossRef
2.
Stuebner E, Vichayanrat E, Low DA, Mathias CJ, Isenmann S, Haensch CA (2013) Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson’s disease. Front Neurol 4:49PubMedCentralPubMedCrossRef
3.
Okamoto LE, Gamboa A, Shibao C, Black BK, Diedrich A, Raj SR et al (2009) Nocturnal blood pressure dipping in the hypertension of autonomic failure. Hypertension 53(2):363–369PubMedCentralPubMedCrossRef
4.
Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C (1998) Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson’s disease and multiple system atrophy. J Hypertens 16(10):1433–1441PubMedCrossRef
5.
Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y (2003) Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 42(2):136–142PubMedCrossRef
6.
Rose KM, Tyroler HA, Nardo CJ, Arnett DK, Light KC, Rosamond W et al (2000) Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities study. Am J Hypertens 13(6 Pt 1):571–578PubMedCrossRef
7.
Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D (2000) Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987–1996. Stroke 31(10):2307–2313PubMedCrossRef
8.
Fedorowski A, Engstrom G, Hedblad B, Melander O (2010) Orthostatic hypotension predicts incidence of heart failure: the Malmo preventive project. Am J Hypertens 23(11):1209–1215PubMedCrossRef
9.
Fedorowski A, Hedblad B, Engstrom G, Gustav Smith J, Melander O (2010) Orthostatic hypotension and long-term incidence of atrial fibrillation: the malmo preventive project. J Intern Med 268(4):383–389PubMedCrossRef
10.
Fedorowski A, Stavenow L, Hedblad B, Berglund G, Nilsson PM, Melander O (2010) Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals: the malmo preventive project. Eur Heart J 31(1):85–91PubMedCentralPubMedCrossRef
11.
Parati G, Ochoa JE, Lombardi C, Bilo G (2013) Assessment and management of blood-pressure variability. Nat Rev Cardiol 10(3):143–155PubMedCrossRef
12.
Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H (2000) Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 355(9205):725–726PubMedCrossRef
13.
Maule S, Milan A, Grosso T, Veglio F (2006) Left ventricular hypertrophy in patients with autonomic failure. Am J Hypertens 19(10):1049–1054PubMedCrossRef
14.
Gambardella S, Frontoni S, Spallone V, Maiello MR, Civetta E, Lanza G et al (1993) Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy. Am J Hypertens 6(2):97–102PubMed
15.
Pop-Busui R, Cleary PA, Braffett BH, Martin CL, Herman WH, Low PA et al (2013) Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (diabetes control and complications trial/epidemiology of diabetes interventions and complications). J Am Coll Cardiol 61(4):447–454PubMedCentralPubMedCrossRef
16.
Irace L, Iarussi D, Guadagno I, Tedesco MA, Perna B, Ratti G et al (1996) Left ventricular performance and autonomic dysfunction in patients with long-term insulin-dependent diabetes mellitus. Acta Diabetol 33(4):269–273PubMedCrossRef
17.
Taskiran M, Rasmussen V, Rasmussen B, Fritz-Hansen T, Larsson HB, Jensen GB et al (2004) Left ventricular dysfunction in normotensive Type 1 diabetic patients: the impact of autonomic neuropathy. Diabet Med 21(6):524–530PubMedCrossRef
18.
Karamitsos TD, Karvounis HI, Didangelos T, Parcharidis GE, Karamitsos DT (2008) Impact of autonomic neuropathy on left ventricular function in normotensive type 1 diabetic patients: a tissue Doppler echocardiographic study. Diabetes Care 31(2):325–327PubMedCrossRef
19.
Mogensen UM, Jensen T, Kober L, Kelbaek H, Mathiesen AS, Dixen U et al (2012) Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients. Diabetes 61(7):1822–1830PubMedCentralPubMedCrossRef
20.
Willenheimer RB, Erhardt LR, Nilsson H, Lilja B, Juul-Moller S, Sundkvist G (1998) Parasympathetic neuropathy associated with left ventricular diastolic dysfunction in patients with insulin-dependent diabetes mellitus. Scand Cardiovasc J 32(1):17–22PubMedCrossRef
21.
Huijben AM, Mattace-Raso FU, Deinum J, Lenders J, van den Meiracker AH (2012) Aortic augmentation index and pulse wave velocity in response to head-up tilting: effect of autonomic failure. J Hypertens 30(2):307–314PubMedCrossRef
22.
Meyer C, Milat F, McGrath BP, Cameron J, Kotsopoulos D, Teede HJ (2004) Vascular dysfunction and autonomic neuropathy in Type 2 diabetes. Diabet Med 21(7):746–751PubMedCrossRef
23.
van Ittersum FJ, Schram MT, van der Heijden-Spek JJ, Van Bortel LM, Elte JW, Biemond P et al (2004) Autonomic nervous function, arterial stiffness and blood pressure in patients with Type I diabetes mellitus and normal urinary albumin excretion. J Hum Hypertens 18(11):761–768PubMedCrossRef
24.
Prince CT, Secrest AM, Mackey RH, Arena VC, Kingsley LA, Orchard TJ (2010) Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes. Diabetes Care 33(3):652–657PubMedCentralPubMedCrossRef
25.
Liatis S, Alexiadou K, Tsiakou A, Makrilakis K, Katsilambros N, Tentolouris N (2011) Cardiac autonomic function correlates with arterial stiffness in the early stage of type 1 diabetes. Exp Diabetes Res 2011:957901PubMedCentralPubMedCrossRef
26.
Secrest AM, Marshall SL, Miller RG, Prince CT, Orchard TJ (2011) Pulse wave analysis and cardiac autonomic neuropathy in type 1 diabetes: a report from the Pittsburgh epidemiology of diabetes complications study. Diabetes Technol Ther 13(12):1264–1268PubMedCentralPubMedCrossRef
27.
Theilade S, Lajer M, Persson F, Joergensen C, Rossing P (2013) Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes. Diabetes Care 36(3):715–721PubMedCentralPubMedCrossRef
28.
Nemes A, Takacs R, Gavaller H, Varkonyi TT, Wittmann T, Forster T et al (2010) Correlations between aortic stiffness and parasympathetic autonomic function in healthy volunteers. Can J Physiol Pharmacol 88(12):1166–1171PubMedCrossRef
29.
Gottsäter A, Ryden-Ahlgren A, Szelag B, Hedblad B, Persson J, Berglund G et al (2003) Cardiovascular autonomic neuropathy associated with carotid atherosclerosis in Type 2 diabetic patients. Diabet Med 20(6):495–499PubMedCrossRef
30.
Sinha PK, Santr G, De D, Sah A, Biswas K, Bhattachary P et al (2012) Carotid intima-media thickness in type 2 diabetes mellitus patients with cardiac autonomic neuropathy. J Assoc Physicians India 60:14–18PubMed
31.
Jung CH, Baek AR, Kim KJ, Kim BY, Kim CH, Kang SK et al (2013) Association between Cardiac Autonomic Neuropathy, Diabetic Retinopathy and Carotid Atherosclerosis in Patients with Type 2 Diabetes. Endocrinol Metab (Seoul) 28(4):309–319CrossRef
32.
Gottsäter A, Ahlgren AR, Taimour S, Sundkvist G (2006) Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes. Clin Auton Res 16(3):228–234PubMedCrossRef
33.
Canani LH, Copstein E, Pecis M, Friedman R, Leitao CB, Azevedo MJ et al (2013) Cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients with peripheral artery disease. Diabetol Metab Syndr 5(1):54PubMedCentralPubMedCrossRef
34.
Garland EM, Gamboa A, Okamoto L, Raj SR, Black BK, Davis TL et al (2009) Renal impairment of pure autonomic failure. Hypertension 54(5):1057–1061PubMedCentralPubMedCrossRef
35.
Torffvit O, Lindqvist A, Agardh CD, Pahlm O (1997) The association between diabetic nephropathy and autonomic nerve function in type 1 diabetic patients. Scand J Clin Lab Invest 57(2):183–191PubMedCrossRef
36.
Pavy-Le Traon A, Fontaine S, Tap G, Guidolin B, Senard JM, Hanaire H (2010) Cardiovascular autonomic neuropathy and other complications in type 1 diabetes. Clin Auton Res 20:153–160PubMedCrossRef
37.
Kim YK, Lee JE, Kim YG, Kim DJ, Oh HY, Yang CW et al (2009) Cardiac autonomic neuropathy as a predictor of deterioration of the renal function in normoalbuminuric, normotensive patients with type 2 diabetes mellitus. J Korean Med Sci 24(Suppl):S69–S74PubMedCentralPubMedCrossRef
38.
Bilal N, Erdogan M, Ozbek M, Cetinkalp S, Karadeniz M, Ozgen AG et al (2008) Increasing severity of cardiac autonomic neuropathy is associated with increasing prevalence of nephropathy, retinopathy, and peripheral neuropathy in Turkish type 2 diabetics. J Diabetes Complicat 22:181–185PubMedCrossRef
39.
Lim TS, Lee PH, Kim HS, Yong SW (2009) White matter hyperintensities in patients with multiple system atrophy. J Neurol 256(10):1663–1670PubMedCrossRef
40.
Umoto M, Miwa H, Ando R, Kajimoto Y, Kondo T (2012) White matter hyperintensities in patients with multiple system atrophy. Parkinsonism Relat Disord 18(1):17–20PubMedCrossRef
41.
Tha KK, Terae S, Yabe I, Miyamoto T, Soma H, Zaitsu Y et al (2010) Microstructural white matter abnormalities of multiple system atrophy: in vivo topographic illustration by using diffusion-tensor MR imaging. Radiology 255(2):563–569PubMedCrossRef
42.
Oh YS, Kim JS, Yang DW, Koo JS, Kim YI, Jung HO et al (2013) Night time blood pressure and white matter hyperintensities in patients with Parkinson disease. Chronobiol Int 30(6):811–817PubMedCrossRef
43.
Struhal W, Lahrmann H, Mathias CJ (2013) Incidence of cerebrovascular lesions in pure autonomic failure. Auton Neurosci 179(1–2):159–162PubMedCrossRef
44.
Toyry JP, Niskanen LK, Lansimies EA, Partanen KP, Uusitupa MI (1996) Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 27(8):1316–1318PubMedCrossRef
45.
Cohen JA, Estacio RO, Lundgren RA, Esler AL, Schrier RW (2003) Diabetic autonomic neuropathy is associated with an increased incidence of strokes. Auton Neurosci 108(1–2):73–78PubMedCrossRef
46.
Ko SH, Song KH, Park SA, Kim SR, Cha BY, Son HY et al (2008) Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up study. Diabet Med 25(10):1171–1177PubMedCrossRef
47.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31(7):1281–1357PubMedCrossRef
48.
Leoncini G, Viazzi F, Storace G, Deferrari G, Pontremoli R (2013) Blood pressure variability and multiple organ damage in primary hypertension. J Hum Hypertens 27(11):663–670PubMedCrossRef
49.
Cuspidi C, Meani S, Salerno M, Valerio C, Fusi V, Severgnini B et al (2004) Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens 22(2):273–280PubMedCrossRef
50.
Fan XH, Wang Y, Sun K, Zhang W, Wang H, Wu H et al (2010) Disorders of orthostatic blood pressure response are associated with cardiovascular disease and target organ damage in hypertensive patients. Am J Hypertens 23(8):829–837PubMedCrossRef
51.
Franceschini N, Rose KM, Astor BC, Couper D, Vupputuri S (2010) Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study. Hypertension 56(6):1054–1059PubMedCentralPubMedCrossRef
52.
Melillo P, Izzo R, De Luca N, Pecchia L (2012) Heart rate variability and target organ damage in hypertensive patients. BMC Cardiovasc Disord 12:105PubMedCentralPubMedCrossRef
53.
Schillaci G, Bilo G, Pucci G, Laurent S, Macquin-Mavier I, Boutouyrie P et al (2012) Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension 60(2):369–377PubMedCrossRef
54.
Protogerou AD, Stergiou GS, Lourida P, Achimastos A (2008) Arterial stiffness and orthostatic blood pressure changes in untreated and treated hypertensive subjects. J Am Soc Hypertens 2:372–377PubMedCrossRef
55.
Valbusa F, Labat C, Salvi P, Vivian ME, Hanon O, Benetos A (2012) Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study. J Hypertens 30(1):53–60PubMedCrossRef
56.
Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D (1979) Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med 301(2):68–73PubMedCrossRef
57.
Biaggioni I, Garcia F, Inagami T, Haile V (1993) Hyporeninemic normoaldosteronism in severe autonomic failure. J Clin Endocrinol Metab 76(3):580–586PubMed
58.
Arnold AC, Okamoto LE, Gamboa A, Shibao C, Raj SR, Robertson D et al (2013) Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension 61(3):701–706PubMedCentralPubMedCrossRef
59.
Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ et al (2010) Effects of cardiac autonomic dysfunction on mortality risk in the action to control cardiovascular risk in diabetes (ACCORD) trial. Diabetes Care 33(7):1578–1584PubMedCentralPubMedCrossRef
60.
Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S et al (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12(3):264–274PubMedCentralPubMedCrossRef
61.
Papapetropoulos S, Tuchman A, Laufer D, Papatsoris AG, Papapetropoulos N, Mash DC (2007) Causes of death in multiple system atrophy. J Neurol Neurosurg Psychiatry 78(3):327–329PubMedCentralPubMedCrossRef
62.
Shimohata T, Ozawa T, Nakayama H, Tomita M, Shinoda H, Nishizawa M (2008) Frequency of nocturnal sudden death in patients with multiple system atrophy. J Neurol 255(10):1483–1485PubMedCrossRef
63.
Maule S, Milazzo V, Maule MM, Di Stefano C, Milan A, Veglio F (2012) Mortality and prognosis in patients with neurogenic orthostatic hypotension. Funct Neurol 27:101–106PubMedCentralPubMed
64.
Mabuchi N, Hirayama M, Koike Y, Watanabe H, Ito H, Kobayashi R et al (2005) Progression and prognosis in pure autonomic failure (PAF): comparison with multiple system atrophy. J Neurol Neurosurg Psychiatry 76(7):947–952PubMedCentralPubMedCrossRef
65.
Gorell JM, Johnson CC, Rybicki BA (1994) Parkinson’s disease and its comorbid disorders: an analysis of Michigan mortality data, from 1970 to 1990. Neurology 44(10):1865–1868PubMedCrossRef
66.
Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G (2008) Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Neurology 70(16 Pt 2):1423–1430PubMedCrossRef
67.
Oh YS, Kim JS, Lee KS (2013) Orthostatic and supine blood pressures are associated with white matter hyperintensities in Parkinson disease. J Mov Disord 6(2):23–27PubMedCentralPubMedCrossRef
Metadaten
Titel
Cardiovascular complications in patients with autonomic failure
verfasst von
Valeria Milazzo
Cristina Di Stefano
Alberto Milan
Agnese Ravera
Gabriele Sobrero
Luca Sabia
Franco Veglio
Simona Maule
Publikationsdatum
01.06.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Autonomic Research / Ausgabe 3/2015
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-015-0275-0

Weitere Artikel der Ausgabe 3/2015

Clinical Autonomic Research 3/2015 Zur Ausgabe

Short Communication

Cardiovagal and somatic sensory nerve functions in healthy subjects

Review Article

The function of the autonomic nervous system during spaceflight

Review Article

Sweating on the palm and sole: physiological and clinical relevance

Research Article

Treatment of compensatory hyperhidrosis after sympathectomy with botulinum toxin and anticholinergics

Case Report

Transient global amnesia and broken heart syndrome: two faces of one pathology

Letter to the Editor

Transient global amnesia and Takotsubo syndrome: would cerebral blood flow brain scan be of any help?

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Bildnachweise